Literature DB >> 26428657

Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.

Yi Fan1, Ruiye Bi1, Michael J Densmore1, Tadatoshi Sato1, Tatsuya Kobayashi1, Quan Yuan1, Xuedong Zhou1, Reinhold G Erben1, Beate Lanske2.   

Abstract

Parathyroid-hormone-type 1 receptor (PTH1R) is extensively expressed in key regulatory organs for systemic mineral ion homeostasis, including kidney and bone. We investigated the bone-specific functions of PTH1R in modulating mineral ion homeostasis by generating a novel mouse model in which PTH1R is ablated in the limb mesenchyme using Prx1Cre transgenic mice. Such ablation decreased FGF23 protein and serum levels by 50%, despite normal Fgf23 mRNA levels in long bones. Circulating calcium and PTH levels were unchanged, but inorganic phosphate and 1,25(OH)2D3 levels were significantly decreased and accompanied by elevated urinary calcium and phosphate wasting. Key renal genes for balancing mineral ion homeostasis, calbindinD28k, Klotho, and Napi2a were suppressed by 30-40%. Intermittent hPTH(1-34) injections increased Fgf23 mRNA (7.3-fold), Nurr1 mRNA (3.1-fold), and serum intact-FGF23 (1.6-fold) in controls, but failed to induce Fgf23, Nurr1 mRNA, or intact FGF23 production in mutants. Moreover, a significant elevation in serum C-terminal-FGF23 levels (4-fold) was detected in both genotypes. PTH markedly downregulated Galnt3 expression (2.7-fold) in controls but not in mutants. These results demonstrate the pivotal role of PTH1R in long bones to regulate systemic mineral ion homeostasis and the direct induction of FGF23 by PTH1R signaling. © FASEB.

Entities:  

Keywords:  Galnt3; calcium/phosphate metabolism; kidney-bone mineral diseases

Mesh:

Substances:

Year:  2015        PMID: 26428657      PMCID: PMC4684518          DOI: 10.1096/fj.15-278184

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

Authors:  Vardit Lavi-Moshayoff; Gilad Wasserman; Tomer Meir; Justin Silver; Tally Naveh-Many
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

2.  Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.

Authors:  Hannes Olauson; Karolina Lindberg; Risul Amin; Ting Jia; Annika Wernerson; Göran Andersson; Tobias E Larsson
Journal:  J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 10.121

3.  Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties.

Authors:  A E Nelson; J J Hogan; I A Holm; B G Robinson; R S Mason
Journal:  Bone       Date:  2001-04       Impact factor: 4.398

4.  A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.

Authors:  E Schipani; K Kruse; H Jüppner
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

Review 5.  Calcium metabolism in health and disease.

Authors:  Munro Peacock
Journal:  Clin J Am Soc Nephrol       Date:  2010-01       Impact factor: 8.237

Review 6.  Active Ca(2+) reabsorption in the connecting tubule.

Authors:  Sandor Boros; René J M Bindels; Joost G J Hoenderop
Journal:  Pflugers Arch       Date:  2008-11-07       Impact factor: 3.657

7.  Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.

Authors:  A C Karaplis; B He; M T Nguyen; I D Young; D Semeraro; H Ozawa; N Amizuka
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

8.  Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.

Authors:  A S Jobert; P Zhang; A Couvineau; J Bonaventure; J Roume; M Le Merrer; C Silve
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

9.  Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.

Authors:  Tomer Meir; Karina Durlacher; Zheng Pan; Gail Amir; William G Richards; Justin Silver; Tally Naveh-Many
Journal:  Kidney Int       Date:  2014-06-18       Impact factor: 10.612

Review 10.  Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  David W Dempster; Juliet E Compston; Marc K Drezner; Francis H Glorieux; John A Kanis; Hartmut Malluche; Pierre J Meunier; Susan M Ott; Robert R Recker; A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more
  24 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  The Pas de Trois of Vitamin D, FGF23, and PTH.

Authors:  Tally Naveh-Many; Justin Silver
Journal:  J Am Soc Nephrol       Date:  2016-11-02       Impact factor: 10.121

3.  A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23.

Authors:  Qing He; Lauren T Shumate; Julia Matthias; Cumhur Aydin; Marc N Wein; Jordan M Spatz; Regina Goetz; Moosa Mohammadi; Antonius Plagge; Paola Divieti Pajevic; Murat Bastepe
Journal:  JCI Insight       Date:  2019-09-05

4.  Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.

Authors:  Pelin Balcik-Ercin; Metin Cetin; Irem Yalim-Camci; Gorkem Odabas; Nurettin Tokay; A Emre Sayan; Tamer Yagci
Journal:  Cell Oncol (Dordr)       Date:  2018-03-07       Impact factor: 6.730

Review 5.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

6.  Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.

Authors:  Loan Nguyen-Yamamoto; Andrew C Karaplis; Rene St-Arnaud; David Goltzman
Journal:  J Am Soc Nephrol       Date:  2016-08-17       Impact factor: 10.121

7.  Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels.

Authors:  Vanessa M Knab; Braden Corbin; Olena Andrukhova; Julia M Hum; Pu Ni; Seham Rabadi; Akira Maeda; Kenneth E White; Reinhold G Erben; Harald Jüppner; Marta Christov
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

8.  Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.

Authors:  Liping Xiao; Erxia Du; Collin Homer-Bouthiette; Marja M Hurley
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

9.  Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.

Authors:  Yi Fan; Jun-Ichi Hanai; Phuong T Le; Ruiye Bi; David Maridas; Victoria DeMambro; Carolina A Figueroa; Serkan Kir; Xuedong Zhou; Michael Mannstadt; Roland Baron; Roderick T Bronson; Mark C Horowitz; Joy Y Wu; John P Bilezikian; David W Dempster; Clifford J Rosen; Beate Lanske
Journal:  Cell Metab       Date:  2017-02-02       Impact factor: 27.287

10.  Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.

Authors:  Yi Fan; Weiqing Liu; Ruiye Bi; Michael J Densmore; Tadatoshi Sato; Michael Mannstadt; Quan Yuan; Xuedong Zhou; Hannes Olauson; Tobias E Larsson; Hakan R Toka; Martin R Pollak; Edward M Brown; Beate Lanske
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.